Lotte Deroover SRL
Lotte Deroover reported total assets of 39,701 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026).
The score of Lotte Deroover shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity -65 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lotte Deroover's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 15 Aug 2024
Lotte Deroover's financial analysis
- Solvency10.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lotte Deroover
Lotte Deroover's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0797.492.230
- VAT number
- BE0797492230
- Peppol
- Registered · 0208:0797492230 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jan 2023
- Registered office
- 3191 Boortmeerbeek
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lotte Deroover (SRL) has been based in Boortmeerbeek since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 7,166 € and equity of 4,288 €; its revenue is not published. Its solvency stands at 10.8%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Lotte Deroover
Companies in the same business, of comparable size and area, outside its group.
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- AVICENNE Pharma Services Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 42,747 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
- Smilla Retail sale of pharmaceutical products Heers · balance sheet 70,168 €
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
- Laphare Retail sale of pharmaceutical products Mettet · balance sheet 49,090 €
Frequently asked questions about Lotte Deroover
What is the revenue of Lotte Deroover?
Lotte Deroover files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lotte Deroover?
In Belgium, the VAT number is the company number prefixed with BE: BE0797492230 for Lotte Deroover, if the company is VAT-registered. Its company number (CBE) is 0797.492.230.
Where is the registered office of Lotte Deroover?
According to the CBE register, the registered office of Lotte Deroover is in 3191 Boortmeerbeek.
What is the equity of Lotte Deroover?
At the close of the 2025 financial year, the equity of Lotte Deroover amounts to 4,288 €, a solvency of 10.8% of total assets.
Who manages Lotte Deroover?
The register lists 1 active mandates at Lotte Deroover. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lotte Deroover
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →